# Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence

> **NCT05487456** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 74 (actual)

## Conditions studied

- Nicotine
- Vaping
- Nicotine Vaping

## Interventions

- **OTHER:** P4M3 CA35
- **OTHER:** P4M3 CM35
- **OTHER:** CIG
- **OTHER:** Smoking Abstinence

## Key facts

- **NCT ID:** NCT05487456
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-15
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-11-07
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05487456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05487456, "Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05487456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*